BRRN.OTC.PinkByrn, INC

10-Q: BYRN INC. Reports Deepening Losses and Internal Control Deficiencies Amidst Dormant Operations

Sentiment:

Quarterly Report


BYRN INC. reported a net loss of $24,882 for the six months ended June 30, 2025, with no revenue and significant internal control weaknesses, as it continues to operate as a dormant shell company seeking a reverse merger.

Capital raiseThe company will need to raise additional funds and is currently exploring alternative sources of financing.Historically, capital has been raised through private placements, and the company may continue to raise additional capital through the sale of common stock or other securities and obtaining short-term loans.The company intends to pay for consulting services with its common stock where feasible to maximize working capital.If a reverse merger is closed, it is likely that capital will be needed as a condition of closing that acquisition.Future issuances of equity or convertible debt securities are expected to result in dilution to current shareholders.Such securities might have rights, preferences, or privileges senior to the Common Stock.
Worse than expectedNet loss significantly increased to $24,882 for the six months ended June 30, 2025, from $4,110 in the prior year, indicating a worsening financial performance.Total liabilities increased to $81,468 from $56,586, and related party payables increased to $78,935 from $43,234, showing an increase in financial obligations.The company's working capital deficit and negative shareholders' equity worsened, indicating a deteriorating financial position.Management concluded that disclosure controls and internal control over financial reporting were not effective, highlighting significant operational deficiencies.

Summary

  • BYRN INC. is a dormant shell company with no current operations or revenue.
  • The company reported a net loss of $24,882 for the six months ended June 30, 2025, a significant increase from $4,110 for the same period in 2024.
  • Total operating expenses, primarily administrative expenses related to a related party, increased to $24,882 for the six months ended June 30, 2025, from $4,110 in the prior year period.
  • As of June 30, 2025, total liabilities stood at $81,468, up from $56,586 at December 31, 2024, with related party payables accounting for $78,935.
  • The company had a working capital deficit of $81,468 and a negative shareholders' equity of $117,546,993 as of June 30, 2025.
  • Cash and cash equivalents remained at $0 for both June 30, 2025, and December 31, 2024.
  • Net cash used in operating activities was $35,700 for the six months ended June 30, 2025, which was entirely funded by proceeds from related party loans.
  • Management intends to explore and identify business opportunities within the U.S., including potential acquisitions via reverse merger, asset purchase, or similar transactions.
  • Management concluded that disclosure controls and internal control over financial reporting were not effective as of June 30, 2025, citing material weaknesses such as insufficient segregation of duties, lack of an independent board or audit committee, and absence of written internal control policies.

Sentiment

Score: 2

Explanation: The company is a dormant shell with no operations or revenue, increasing losses, significant accumulated deficit, and ineffective internal controls. Its future is entirely dependent on a speculative reverse merger and capital raises, which will be highly dilutive. The only positive is the stated intention to find a business, but this is highly uncertain.

Positives

  • Management is actively exploring business opportunities, including potential reverse mergers, to establish future operations.
  • A clear plan is outlined to rectify identified internal control weaknesses by implementing an independent board, establishing written policies, and hiring additional accounting personnel upon completing a business acquisition.

Negatives

  • The company has no operations or revenue from continuing business activities.
  • Net loss significantly increased to $24,882 for the six months ended June 30, 2025, compared to $4,110 for the same period in 2024.
  • Total assets are $0, indicating a complete lack of operational assets.
  • A working capital deficit of $81,468 and negative shareholders' equity of $117,546,993 as of June 30, 2025, highlight severe financial distress.
  • The company is entirely reliant on interest-free demand loans from a related party (David Lazar) for funding operating activities.
  • Disclosure controls and internal control over financial reporting were deemed ineffective as of June 30, 2025, due to material weaknesses.
  • Material weaknesses in internal controls include insufficient segregation of duties, absence of an independent board or audit committee, and lack of written internal control policies.
  • Operating losses are anticipated to continue for the next 12 months, primarily due to SEC reporting obligations.
  • There is no assurance that management can identify and implement a viable business strategy or that any such strategy will result in profits.

Risks

  • Limited management, labor, and financial resources pose significant operational challenges.
  • The ability to establish and maintain adequate internal controls is uncertain, as current controls are deemed ineffective.
  • Challenges exist in developing and maintaining a market for the company's securities.
  • Obtaining necessary financing, if and when needed, on acceptable terms is not assured.
  • The company's ability to effectively identify, develop, and implement a viable business plan may be hindered by risks beyond its control, including the continued negative effects of the coronavirus pandemic.
  • Lack of diversification is a substantial risk, as the company anticipates only being able to effect one business combination due to limited capital.
  • Any target business acquired may be financially unstable or in early stages of development, exposing the company to inherent risks.
  • The company may effect a business combination in an industry characterized by high risk or where management has limited experience.
  • Competition from other firms seeking business opportunities at discounted rates could complicate acquisition efforts.
  • The selection of a business combination is expected to be a complex and risk-prone process.
  • Anticipated operating losses in the next 12 months, primarily from SEC reporting costs, will further deplete resources.
  • Risks inherent in early-stage development companies include an evolving and unpredictable business model, challenges in recognizing revenue sources, and difficulties in managing growth.
  • Failure to attract, retain, and motivate qualified personnel could adversely affect business prospects.
  • Future issuances of equity or convertible debt securities will result in significant dilution to current shareholders.
  • Such future securities might have rights, preferences, or privileges senior to the Common Stock.

Future Outlook

Management intends to explore and identify viable business opportunities within the U.S., including seeking to acquire an operating entity through a reverse merger, asset purchase, or similar transaction. The company anticipates incurring operating losses in the next 12 months, primarily due to SEC reporting obligations, and expects to need additional capital to fund operations and potentially as a condition for closing any acquisition.

Management Comments

  • Management intends to explore and identify business opportunities within the U.S., including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction.
  • Our Chief Executive Officer has experience in business consulting, although no assurances can be given that he can identify and implement a viable business strategy or that any such strategy will result in profits.
  • We do not currently engage in any business activities that provide revenue or cash flow.
  • Our management anticipates that we will likely only be able to effect one business combination due to our limited capital. This lack of diversification will likely pose a substantial risk in investing in the Company for the indefinite future.
  • We anticipate that the selection of a business combination will be a complex and risk-prone process.
  • Based upon our current operations, we do not have sufficient working capital to fund our operations over the next 12 months.
  • If we are able to close a reverse merger, it is likely we will need capital as a condition of closing that acquisition.
  • Because of the uncertainties, we cannot be certain as to how much capital we need to raise or the type of securities we will be required to issue.
  • In connection with a reverse merger, we will be required to issue a controlling block of our securities to the targets shareholders which will be very dilutive.
  • Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders.
  • Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development.
  • Management has concluded that our disclosure controls were not effective as of June 30, 2025.
  • Our internal control over financial reporting was not effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles as a result of material weaknesses.
  • We plan to rectify these weaknesses by implementing an independent board of directors, establishing written policies and procedures for our internal control of financial reporting, and hiring additional accounting personnel at such time as we complete a reverse merger or similar business acquisition.

Industry Context

BYRN INC. operates as a dormant shell company, a common structure used for reverse mergers or acquisitions, particularly by entities seeking access to public markets without a traditional IPO. Its current state reflects a broader trend of companies existing primarily to facilitate future business combinations, often in the early stages of development or in need of capital. The company's stated intention to acquire a healthcare knowledge solution company aligns with the growing demand for technology-driven efficiencies and data analytics within the healthcare sector, though its current lack of operations places it far from contributing to or competing within this industry.

Comparison to Industry Standards

  • As a dormant shell company with no operations or revenue, BYRN INC. cannot be directly compared to active industry players or global benchmarks in the healthcare knowledge solution sector.
  • Its financial metrics, such as zero revenue and consistent losses, are typical for a shell entity.
  • The significant accumulated deficit and reliance on related-party funding are also common for companies in this pre-operational phase.
  • The identified material weaknesses in internal controls, including a lack of segregation of duties and an independent board, are below standard corporate governance practices for publicly traded companies, regardless of size or operational status, and would be a red flag for investors comparing it to more mature or well-governed entities like established healthcare tech firms (e.g., Cerner, Epic, or smaller publicly traded health IT companies).

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control DeficiencyManagement concluded that disclosure controls and internal control over financial reporting were not effective as of June 30, 2025.2025-06-30Indicates significant weaknesses in financial reporting oversight and compliance, potentially leading to misstatements or lack of transparency.
Material WeaknessInsufficient segregation of duties within accounting functions due to only having one officer and limited resources.2025-06-30Increases the risk of errors or fraud going undetected due to lack of checks and balances.
Material WeaknessAbsence of an independent board of directors or an audit committee.2025-06-30Lacks independent oversight crucial for corporate governance, investor protection, and financial integrity.
Material WeaknessAbsence of written documentation of internal control policies and procedures.2025-06-30Hinders consistent application of controls, training, and accountability, making it difficult to assess and improve control effectiveness.
Material WeaknessAll financial reporting is carried out by a financial consultant.2025-06-30Reliance on a single external party for critical financial functions can introduce risks related to expertise, independence, and continuity.

Related Party Transactions

  • David Lazar, the company's Court-appointed custodian, is considered a related party.
  • During the three months ended June 30, 2025, Mr. Lazar extended $20,404 in interest-free demand loans to the company.
  • As of June 30, 2025, the total amount due to Mr. Lazar was $78,935.
  • Administrative expenses, totaling $24,882 for the six months ended June 30, 2025, are entirely related party expenses.
  • Net cash provided by financing activities ($35,700 for six months ended June 30, 2025) entirely consists of proceeds from related party loans.

Stakeholder Impact

  • Shareholders face significant dilution risk from future equity issuances required for capital raises or a reverse merger, with current shares having no underlying operational value.
  • Creditors, primarily David Lazar, the related party, are extending interest-free demand loans, indicating a high reliance on a single individual for funding.
  • Potential investors would need to be aware of the company's shell status, lack of operations, significant accumulated deficit, and material weaknesses in internal controls, making it a high-risk, speculative investment.

Next Steps

  • Management intends to explore and identify viable business opportunities within the U.S.
  • Seeking to acquire an operating entity through a reverse merger, asset purchase, or similar transaction.
  • Incurring costs in connection with investigating, evaluating, and negotiating potential business combinations.
  • Filing SEC reports.
  • Consummating an acquisition of an operating business.
  • Raising additional funds through alternative sources of financing, including private placements, sale of common stock or other securities, and short-term loans.
  • Implementing an independent board of directors.
  • Establishing written policies and procedures for internal control of financial reporting.
  • Hiring additional accounting personnel upon completion of a reverse merger or similar business acquisition.

Key Dates

DateDescription
2011-04BYRN Inc. (f/k/a Byrn, Inc.) formed as a Nevada corporation.
2011-08-10Holders of majority common stock voted to amend Articles of Incorporation to increase authorized shares to 2,510,000,000 (2,500,000,000 Common, 10,000,000 blank check preferred stock).
2013-03-22Beginning of dormant period for the company.
2019-12-26End of dormant period for the company.
2019-12-27Custodian Ventures, LLC, controlled by David Lazar, appointed by Nevada Court as custodian of Quture.
2019-12-31David Lazar became the only Director and Officer of the Company, acting as President, Treasurer, and Secretary.
2020-04-05Company granted David Lazar 10,000,000 preferred shares with super-voting rights of 21,000,000,000 common shares.
2020-09-10Company filed a Certificate of Designation changing conversion and voting rights of Series A preferred stock to 250 common shares for each 1 Series A preferred share.
2020-09-2310,000,000 shares of Series A Convertible Preferred Stock transferred from Custodian Ventures, LLC to FiveT Capital Holding AG, making FiveT Capital Holding AG the controlling shareholder (approx. 50.2% voting rights). David Lazar released the company from all debts.
2020-09-23Existing director and officer (David Lazar) resigned immediately.
2020-11-24Quture International, Inc. amended articles of incorporation to change its name to Born, Inc. in anticipation of new business operations.
2020-11-24Company amended articles of incorporation to reverse split common stock at 1 for 1,000 and reduced authorized common shares from 2,500,000,000 to 500,000,000.
2020-12-01FINRA declared the Name Change and Reverse Split effective.
2021-02-02Company changed its fiscal year end to December 31.
2021-02-16Company entered into a share exchange agreement with Alkeon Creators, Inc., exchanging 100% ownership of Alkeon for 406,646,919 shares of company common stock. This transaction was later voided.
2021-02Transaction with Alkeon was voided and written off, leading the company to be considered a dormant shell.
2023-07Company went into custodianship.
2024-01-14Eight Judicial District Court issued an Order Barring Unasserted Claims against Born, Inc.
2024-07-16Company changed its name to Byrn Inc.
2024-12-31Fiscal year end for the company.
2025-06-30End of the quarterly period covered by this report.
2025-07-24Date the financial statements were issued and the report was signed.

Recommendation

strong sell

BYRN INC. is a dormant shell company with no operations, no revenue, and a worsening financial position marked by increasing losses and a substantial accumulated deficit. The company is entirely reliant on related-party loans for funding and has significant material weaknesses in its internal controls, including a lack of an independent board and segregation of duties. While management intends to pursue a reverse merger, this is a highly speculative and uncertain endeavor that will result in significant dilution for existing shareholders. The company presents an extremely high-risk profile with no current business fundamentals to support investment, making it unsuitable for all but the most speculative investors willing to risk total loss.

Keywords

Dormant Company, Shell Company, Reverse Merger, SEC Filing, 10-Q, Financial Reporting, Corporate Governance, Internal Controls, Going Concern, Capital Raise, David Lazar, BYRN INC., Healthcare Knowledge Solution, Medical Software

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.